Synergy Therapeutics, Inc

Chimerna Therapeutics Inc, based in New York, NY, is pioneering new advancements in RNA therapeutics. Their innovative Tornado Technology addresses the challenges of RNA instability, paving the way for groundbreaking solutions in treating various diseases such as Alzheimer’s, Parkinson’s, ALS, and NASH. With a focus on developing circular RNA, Chimerna’s platform technology ensures enhanced stability and abundance, setting a new standard in the field. The team, led by experts like CEO Brian Pickering and Chief Scientific Officer Jacob Litke, is dedicated to pushing the boundaries of RNA-based therapies with a strong foundation in research and development. Generated from the website content

Solvias Inc is a leading global provider of ligands, catalysts, and procedures for C-X cross coupling and asymmetric hydrogenation. With locations in Switzerland, France, and the United States, Solvias offers a wide range of solutions for the pharmaceutical and chemical industries. With a strong focus on catalysis technology and custom synthesis, Solvias is committed to delivering high-quality products and services that meet regulatory compliance standards. Through their expertise and innovative approach, Solvias continues to be a trusted partner in the field of chemical research and development.Generated from the website

Morgan & Mendel Genomics Inc., located in Bronx, NY, is dedicated to advancing genomic risk assessment testing through innovative flow cytometry-based technologies. The company's mission is to provide faster, more accurate, and cost-effective genetic testing solutions for assessing cancer risk and therapy candidacy. By commercializing highly precise and low-cost genetic tests, Morgan & Mendel aims to transform the landscape of genomic testing, making it accessible for more individuals. Their commitment to improving the accuracy and affordability of genetic assessments positions them at the forefront of the genomics field. Generated from the website